Group One Trading’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Group One Trading's REGN Position: Q3 2026 in Review
Group One Trading reduced its Regeneron Pharmaceuticals (REGN) stake by 0.19% in Q3 2026, selling an estimated $5.29K and leaving 3,661 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1865.
Group One Trading first reported a position in REGN in Q2 2013 and has held it in 12 quarters since. The position peaked at $4.17M in Q1 2026. 1,426 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Group One Trading held 3,661 shares of Regeneron Pharmaceuticals worth $2.78M as of Q3 2026.
- Group One Trading sold 7 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $5.29K.
- Regeneron Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #1865 holding.
- Group One Trading first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 12 quarters since.
- Group One Trading's Regeneron Pharmaceuticals position peaked at $4.17M in Q1 2026.
- 1,426 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.